Familial Hypercholsterolemia clinical trials

Explore recruiting familial hypercholsterolemia clinical trials.

Also recruiting in Europe

Familial Hypercholsterolemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, single arm, multicenter extension study to evaluate long-term safety and tolerability of inclisiran in participants with heterozygous or homozygous familial hypercholesterolemia who have completed the adolescent ORION-16 or ORION-13 studies (VICTORION-PEDS-OLE)

Germany, Spain, Hungary, Norway, Netherlands, Poland +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Familial Hypercholsterolemia trials by city

Familial Hypercholsterolemia in Toronto Familial Hypercholsterolemia in Vancouver Familial Hypercholsterolemia in Montreal Familial Hypercholsterolemia in Calgary Familial Hypercholsterolemia in Edmonton Familial Hypercholsterolemia in Ottawa Familial Hypercholsterolemia in Winnipeg Familial Hypercholsterolemia in Quebec City Familial Hypercholsterolemia in Hamilton Familial Hypercholsterolemia in Kitchener Familial Hypercholsterolemia in London Familial Hypercholsterolemia in Halifax Familial Hypercholsterolemia in New York Familial Hypercholsterolemia in Los Angeles Familial Hypercholsterolemia in Chicago Familial Hypercholsterolemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease